These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30167038)

  • 1. Advanced breast cancer.
    Naqos N
    Pan Afr Med J; 2018; 29():226. PubMed ID: 30167038
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple-negative breast carcinoma: current and emerging concepts.
    Schmadeka R; Harmon BE; Singh M
    Am J Clin Pathol; 2014 Apr; 141(4):462-77. PubMed ID: 24619745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male occult triple-negative breast cancer.
    Alsayed B; Abdulla HA; Alaskar H; Dhaif A
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31005873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-cadherin and vimentin are useful basal markers in breast cancers.
    Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
    Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 55-Year-Old Woman With New Triple-Negative Breast Mass, Less Than 2 cm on Both Mammogram and Ultrasound.
    Elias AD; Wang WS; Hardesty L
    Oncology (Williston Park); 2016 Mar; 30(3):258-62. PubMed ID: 26984221
    [No Abstract]   [Full Text] [Related]  

  • 6. Misconceptions surrounding pregnancy-associated breast cancer.
    Khalil N; Fowler C
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating tumor cells in patients with triple negative breast cancer during preoperative chemotherapy.
    Lavrov AV; Zubtsova ZhI; Zubtsov DA; Frolova MA; Ignatova EO; Skrypnikova MA; Malysheva EV; Legchenko EV; Petrovskii AV; Utyashev IA; Tyulyandin SA; Gol'dshtein DV
    Bull Exp Biol Med; 2014 May; 157(1):159-61. PubMed ID: 24913582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. My Journey With Triple Negative Breast Cancer.
    Brady L
    Plast Surg Nurs; 2015; 35(3):137-44. PubMed ID: 26313679
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of recurrent breast cancer by ductoscopy.
    Valdes EK; Feldman SM; Balassanian R; Cohen JM; Boolbol SK
    Breast J; 2005; 11(6):506. PubMed ID: 16297117
    [No Abstract]   [Full Text] [Related]  

  • 10. Case of the season. Inflammatory breast cancer.
    Wood J; Collins J; Warner TF
    Semin Roentgenol; 2003 Jan; 38(1):4-6. PubMed ID: 12698586
    [No Abstract]   [Full Text] [Related]  

  • 11. Is secretory breast carcinoma underdiagnosed? In the era of targeted therapy should there be a low threshold to screen for NTRK immunohistochemistry in triple negative breast cancers?
    Zaborowski M; Gill AJ
    Pathology; 2019 Oct; 51(6):653-655. PubMed ID: 31470990
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytological findings in cystic hypersecretory ductal carcinoma of the breast: a potential pitfall in mammary cytology.
    Schmitt F; Tani E
    Cytopathology; 2000 Dec; 11(6):513-9. PubMed ID: 11194083
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
    Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ductal carcinoma in situ of the breast.
    Yoshida M; Kinoshita T
    Jpn J Clin Oncol; 2009 Feb; 39(2):132. PubMed ID: 19155284
    [No Abstract]   [Full Text] [Related]  

  • 15. Infiltrating ductal carcinoma of the breast with osseous metaplasia: imaging findings with pathologic correlation.
    Evans HA; Shaughnessy EA; Nikiforov YE
    AJR Am J Roentgenol; 1999 May; 172(5):1420-2. PubMed ID: 10227530
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the X-linked inhibitor of apoptosis protein for invasive ductal breast cancer with triple-negative phenotype.
    Wang J; Liu Y; Ji R; Gu Q; Zhao X; Liu Y; Sun B
    Hum Pathol; 2010 Aug; 41(8):1186-95. PubMed ID: 20381828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast tumor revealed by a gastric metastasis discovered incidentally].
    Moussaoui AE; Assi F; Bental A
    Pan Afr Med J; 2016; 24():318. PubMed ID: 28154673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metaplastic breast cancer: report of a case].
    Babahabib Ma; Chennana A; Hachi A; Kouach J; Moussaoui D; Dhayni M
    Pan Afr Med J; 2014; 19():268. PubMed ID: 25870723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nestin-positive microvessel density is an independent prognostic factor in breast cancer.
    Nowak A; Grzegrzolka J; Paprocka M; Piotrowska A; Rys J; Matkowski R; Dziegiel P
    Int J Oncol; 2017 Aug; 51(2):668-676. PubMed ID: 28656248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.